185 related articles for article (PubMed ID: 37700807)
1. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer.
Fang ZX; Hou YY; Wu Z; Wu BX; Deng Y; Wu HT; Liu J
World J Clin Oncol; 2023 Aug; 14(8):297-310. PubMed ID: 37700807
[TBL] [Abstract][Full Text] [Related]
2. Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer.
Fang ZX; Li CL; Chen WJ; Wu HT; Liu J
World J Gastrointest Oncol; 2022 Sep; 14(9):1675-1688. PubMed ID: 36187390
[TBL] [Abstract][Full Text] [Related]
3. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
4. Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma.
Ju MH; Jang EJ; Kang SH; Roh YH; Jeong JS; Han SH
J Hepatocell Carcinoma; 2023; 10():643-658. PubMed ID: 37101765
[TBL] [Abstract][Full Text] [Related]
5. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
6. Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis.
Li M; Zhou C
Transl Cancer Res; 2021 Jun; 10(6):2663-2677. PubMed ID: 35116579
[TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer.
Bao D; Zhang C; Li L; Wang H; Li Q; Ni L; Lin Y; Huang R; Yang Z; Zhang Y; Hu Y
Front Oncol; 2020; 10():553297. PubMed ID: 33614473
[TBL] [Abstract][Full Text] [Related]
8. GHRL as a prognostic biomarker correlated with immune infiltrates and progression of precancerous lesions in gastric cancer.
Wang J; Liu D; Xie Y
Front Oncol; 2023; 13():1142017. PubMed ID: 37469414
[TBL] [Abstract][Full Text] [Related]
9. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.
Zheng P; Liu X; Li H; Gao L; Yu Y; Wang N; Chen H
Front Genet; 2021; 12():796592. PubMed ID: 35126464
[No Abstract] [Full Text] [Related]
10. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
11. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
12. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
13. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
14. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
[TBL] [Abstract][Full Text] [Related]
15. CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers.
Liu Y; Xie S; Zhu K; Guan X; Guo L; Lu R
Heliyon; 2021 Jun; 7(6):e07257. PubMed ID: 34189308
[TBL] [Abstract][Full Text] [Related]
16. The Pan-Cancer Crosstalk Between the
Xie R; Yuan M; Jiang Y
Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
[No Abstract] [Full Text] [Related]
17. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
18. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
[No Abstract] [Full Text] [Related]
19. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
20. Comprehensive analysis of the prognostic value and immune infiltration of
Yang C; Song D; Zhao F; Wu J; Zhang B; Ren H; Sun Q; Qin S
Front Oncol; 2022; 12():936952. PubMed ID: 36147913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
